Almost exactly a year after beginning a recall of some of its implantable defibrillator devices that were found to potentially emit electrical pulses below their programmed strength, Medtronic has ...
The U.S. Food and Drug Administration has approved Minneapolis-based Medtronic’s application to expand the indications for certain pacemakers and defibrillators for patients with heart failure. The ...
EnRhythm(TM) pacemaker and EnTrust(TM) defibrillators now available in Europe Medtronic, Inc. (NYSE:MDT) today announced the European introductions of the Medtronic EnRhythm(TM) pacemaker ...
A Minnesota-based company is recalling more than 348,000 defibrillators over concerns that they may not work. Medtronic, which has its executive headquarters based in Minneapolis, initiated the recall ...
SAN FRANCISCO (MarketWatch) -- Medtronic Inc. said late Thursday that it is voluntarily advising physicians about a potential battery shorting mechanism that may occur in a subset of implantable ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results